Dacarbazine-induced injury in isolated rat hepatocytes
Cell-based study · Primary hepatocytes isolated from male Sprague-Dawley rats (280–300 g) [1]
Dacarbazine caused hepatocyte injury and increased DCF fluorescence. Catalase and other tested antioxidants/scavengers reduced these responses. This is a normal-liver-cell toxicity model, not a melanoma potency assay. The pyridine analogue was tested separately and is excluded from this product record.
| Endpoint | Reported result | Reference |
|---|---|---|
| Hepatocyte viability at 2 h | EC50 56 μM | [1] |
| Trypan-blue-positive cells after 3 h | Cytotoxicity (%) Control: 20 ± 2; DTIC (56 μM): 76 ± 4; DTIC + catalase (200 U/mL): 46 ± 2 | [1] |
| DCF fluorescence after 30 min | Fluorescence intensity units Control: 79 ± 4; DTIC (56 μM): 230 ± 4; DTIC + catalase (200 U/mL): 116 ± 5 | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 56 μM DTIC in mechanistic assays; EC50 is a separate 2-h viability endpoint.
- Exposure duration
- 3 h for cytotoxicity; 30 min for ROS; EC50 determined at 2 h.
- Method
- Isolated hepatocytes (10^6 cells/mL), Krebs-Henseleit buffer pH 7.4, 37°C. Modulators preincubated for 30 min.
- Co-treatment
- Selected rescue comparison: catalase 200 U/mL plus DTIC; compared with DTIC alone and untreated control.
- Reported limits
- DTIC-specific stock solvent is not identified among the water/methanol stock procedures. Dose-response curve and three tested concentrations for EC50 were not shown. Table footnote specifies three separate experiments; number of donor rats is not specified.
Methods and source locations
Compound reported in the paper: Dacarbazine; Compound label in the paper: DTIC
Compound-level cellular toxicity evidence; no inference about Adooq lot performance, clinical liver injury, or anticancer IC50.
Experimental: Chemicals; Isolation and incubation of hepatocytes; Cell viability; ROS assay; Statistical analysis; Results and Discussion, Table 1 and footnotes
Hepatocyte viability at 2 h: Trypan-blue exclusion; authors defined EC50 as concentration reducing viability to 50% after 2 h. Regression used three concentrations; underlying dose-response data/curves were not shown. — Experimental: Isolation and incubation of hepatocytes; Results and Discussion, opening paragraph
Trypan-blue-positive cells after 3 h: Table 1: mean (SD), three separate experiments. DTIC differs from control and catalase combination differs from DTIC (each p < 0.05). — Table 1, None / Dacarbazine / +Catalase rows, cytotoxicity column and footnotes
DCF fluorescence after 30 min: DCFH-DA/DCF fluorimetry; Table 1 mean (SD), three separate experiments. DTIC differs from control and catalase combination differs from DTIC (each p < 0.05). — Table 1, None / Dacarbazine / +Catalase rows, ROS column and footnotes